Control Bionics Reports 34% Sales Revenue Growth

Featured in a writeup by Kalkine Media, Control Bionics is proud to report a 34% sales revenue growth in the December quarter. The article highlighted Control Bionics’ strong sales in the US market, robust pipeline in Australia, two new product launches, and a firm financial footing.

The article points out an “impressive December quarter of 2021”, with growing demand for devices in the assistive and augmentative communication industry. Control Bionics’ innovative devices, like the NeuroNode Trilogy, and new products coming to market make the future look bright.

You'll Also Like

Language at Last: A Cerebral Palsy Case Study

In this new case study, we explore how the therapy team worked together to understand his movement patterns and specifically wrist rotation motion so the NeuroNode could be activated and programmed to his abilities, and how the real Ryan was able to shine through.

Read More ›